Adult linear scleroderma with ptosis: a case report and literature review
10.3760/cma.j.cn113694-20211105-00776
- VernacularTitle:成人线状硬皮病伴眼睑下垂1例并文献复习
- Author:
Pin WANG
1
;
Yingying XU
;
Xiaoyan ZHOU
;
Mengyu WANG
;
Ping WANG
;
Guizhi ZHOU
;
Ling CHENG
;
Lin SUN
;
Jianzhong BI
Author Information
1. 山东大学第二医院神经内科，济南250033
- Keywords:
Scleroderma, limited;
Blepharoptosis;
Facial hemiatrophy;
Demyelinating diseases
- From:
Chinese Journal of Neurology
2022;55(7):732-737
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To discuss the clinical features, diagnosis and treatment of linear scleroderma (LS).Methods:A case of LS diagnosed in the Second Hospital of Shandong University in October 20, 2020, was reported and the clinical features and pathological documentation of the disease reported in the literature were reviewed.Results:A 24-year-old woman presented cicatricial alopecia on the left frontoparietal area and facial atrophy for about 10 years. Two years before, she began to suffer ptosis and neurological complaints. Clinical features of different stages of the disease are presented. All 15 patients reported in the literature were analyzed, with a median of 22 years and a male to female ratio of 9∶6. There were 4 cases of linear scleroderma with ipsilateral drooping eyelids and lateral contraction, 3 cases of linear scleroderma with demyelinating lesions, combined with lateral contraction, 3 cases of linear scleroderma combined with lateral atrophy, and 1 case of linear scleroderma with ipsilateral facial spasm. Two cases were with the chest sclerosing spot. Two cases of linear scleroderma were with epileptic seizure and white matter demyelination lesion. Six cases were treated with hormone, 2 cases were treated with methotrexate. One case was treated with both hormone and methotrexate. One case was treated with botulinum toxin. Three cases were treated with surgical correction of eyelid ptosis. One case was treated with ultraviolet A1 radiation phototherapy and 1 case was treated with vitamin therapy.Conclusions:Patients with scleroderma may have ipsilateral facial atrophy, blepharoptosis and facial spasm. Some patients involving the nervous system may have epilepsy and myelitis. And demyelinating lesions can be seen in magnetic resonance imaging. Localized scleroderma may develop into systemic scleroderma. Therefore, it is recommended to combine immunosuppressants as soon as possible to control the development of the disease if necessary.
